Sagent Pharmaceuticals Inc., a provider of specialty pharmaceutical products with a specific emphasis on the injectables market, has named Allan Oberman as chief executive officer and a member of the board of directors, effective immediately upon receipt of a U.S. work visa. “Allan is a proven leader with impeccable credentials and strategic instincts that will serve Sagent well as we enter our next phase of growth,” said Robert Flanagan, chairman of Sagent’s board of direct...